Drawing for GILGAMESH PHARMACEUTICALS

USPTO serial 88563244

GILGAMESH PHARMACEUTICALS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
โ€”
Examiner
NASSERGHODSI, SAHAR
Law office
TMO LAW OFFICE 115

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with GILGAMESH PHARMACEUTICALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Todd Braverman, Esq.

Todd Braverman, Esq. PEARL COHEN ZEDEK LATZER BARATZ LLP1500 BROADWAY, 12TH FLOORNEW YORK, NY 10036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals, namely, pharmaceutical and drugs preparations and substances in the field of neuroscience for use in the treatment and therapy of psychiatric disorders, depression disorders, substance use, substance abuse, anxiety disorders, cognitive disorders, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), bipolar disorders, eating disorders, pain, and longevity; Diagnostic biomarker reagents for pharmaceutical and medical purposes; predictive biomarker reagents for pharmaceuticals and drugs in the field of neuroscience for use in the treatment and therapy of psychiatric disorders, depression disorders, substance use, substance abuse, anxiety disorders, cognitive disorders, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), bipolar disorders, eating disorders, pain, and longevityACTIVEโ€”

Related trademarks

CopyMark links this record to cited ยง2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 20, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 20, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 28, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDโ€”
Jul 27, 2022EX5GSOU EXTENSION 5 GRANTEDโ€”
Jul 27, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGALโ€”
Jul 11, 2022EXT5SOU EXTENSION 5 FILEDโ€”
Jul 11, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 7, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDโ€”
Jan 5, 2022EX4GSOU EXTENSION 4 GRANTEDโ€”
Jan 5, 2022EXT4SOU EXTENSION 4 FILEDโ€”
Jan 5, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 15, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDโ€”
Jul 13, 2021EX3GSOU EXTENSION 3 GRANTEDโ€”
Jul 13, 2021EXT3SOU EXTENSION 3 FILEDโ€”
Jul 13, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 13, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDโ€”
Jan 11, 2021EX2GSOU EXTENSION 2 GRANTEDโ€”
Jan 11, 2021EXT2SOU EXTENSION 2 FILEDโ€”
Jan 11, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 17, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILEDโ€”
Jul 15, 2020EX1GSOU EXTENSION 1 GRANTEDโ€”
Jul 15, 2020EXT1SOU EXTENSION 1 FILEDโ€”
Jul 15, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 11, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline โ€” usually six months from the notice date.
Dec 17, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILEDโ€”
Dec 17, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 27, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILEDโ€”
Nov 12, 2019ALIEASSIGNED TO LIEโ€”
Nov 6, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTERโ€”
Nov 6, 2019XAECEXAMINER'S AMENDMENT ENTEREDโ€”
Nov 6, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILEDโ€”
Nov 6, 2019GNEAEXAMINERS AMENDMENT E-MAILEDโ€”
Nov 6, 2019CNEAEXAMINERS AMENDMENT -WRITTENโ€”
Nov 6, 2019AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTEREDโ€”
Nov 5, 2019AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTEREDโ€”
Nov 5, 2019PARITEAS VOLUNTARY AMENDMENT RECEIVEDโ€”
Nov 1, 2019DOCKASSIGNED TO EXAMINERโ€”
Aug 21, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTEREDโ€”
Aug 6, 2019NWAPNEW APPLICATION ENTEREDโ€”

Frequently asked questions

Related guidance